Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF Rating $86.87 +0.71 (+0.82%) As of 10/2/2026 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort Interest Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.GSSC Aggregate RatingModerate Buy 2.66Holdings in GSSC have an aggregate rating of Moderate Buy based on 271 analyst ratings issued in the past year covering 23 companies (6.7% of the portfolio).GSSC Aggregate Price Target$86.87High Prediction$86.87Average Prediction$86.87Low Prediction$86.87Holdings in GSSC have an aggregate price target of $86.87 and a range of $86.87 to $86.87 covering 23 companies (6.7% of the portfolio).GSSC Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy3 Buy rating(s)Moderate Buy15 Moderate Buy rating(s)Hold5 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 23 GSSC Holdings ExportWeight In ETFCompanyShare PriceConsensus RatingConsensus Price TargetPossible UpsideNumber of RatingsMarketRank™Indicator(s)ViewRatings0.59%TXG10x Genomics$93.50+5.3%Hold$53.93 -42.3%181.4888 of 5 starsAnalyst Forecast0.42%CDNACareDx$67.15+1.4%Moderate Buy$54.00 -19.6%82.3168 of 5 stars0.35%TVTXTravere Therapeutics$56.93+0.1%Moderate Buy$69.50 22.1%121.7934 of 5 stars0.34%ALKSAlkermes$41.75+3.0%Moderate Buy$54.47 30.5%193.0448 of 5 stars0.33%AAMIAcadian Asset Management$94.17+0.1%Hold$86.33 -8.3%53.3779 of 5 starsNews CoverageAnalyst Upgrade0.30%ATRCAtriCure$55.14+2.9%Moderate Buy$53.30 -3.3%122.3411 of 5 starsAnalyst DowngradeGap Down0.29%ZETAZeta Global$32.75+1.1%Moderate Buy$30.83 -5.9%132.5538 of 5 stars0.28%SNEXStoneX Group$65.81+0.6%Moderate Buy$112.00 70.2%44.0034 of 5 starsNews CoverageAnalyst DowngradeInsider TradeGap Up0.27%TGTXTG Therapeutics$54.29+1.2%Hold$63.00 16.0%93.386 of 5 stars0.27%ENVAEnova International$172.77+0.7%Moderate Buy$231.67 34.1%94.5942 of 5 stars0.26%DAVEDave$346.57+2.1%Moderate Buy$433.25 25.0%174.6868 of 5 starsAnalyst ForecastGap Up0.26%AMRXAmneal Pharmaceuticals$20.30+1.1%Moderate Buy$21.00 3.4%103.3275 of 5 starsAnalyst Forecast0.26%VSATViasat$72.00+2.3%Moderate Buy$90.67 25.9%112.7849 of 5 starsOptions VolumeGap Down0.25%UNFIUnited Natural Foods$45.51+1.6%Hold$52.00 14.3%93.5516 of 5 stars0.25%VSXYVictoria's Secret & Co.$91.77+3.7%Hold$89.91 -2.0%143.8379 of 5 starsAnalyst Forecast0.25%ACADACADIA Pharmaceuticals$19.95+0.3%Moderate Buy$32.76 64.2%184.3563 of 5 starsAnalyst DowngradeAnalyst Revision0.25%UMBFUMB Financial$130.94+0.9%Moderate Buy$165.00 26.0%164.9509 of 5 starsNews CoverageAnalyst Forecast0.24%MOG.AMoog$392.31+0.5%Moderate Buy$462.33 17.8%43.1355 of 5 starsNews Coverage0.24%ANFAbercrombie & Fitch$136.02-0.2%Moderate Buy$155.38 14.2%153.6353 of 5 starsAnalyst Downgrade0.24%ENSEnersys$195.90+3.3%Buy$265.00 35.3%64.6607 of 5 starsNews Coverage0.24%BCRXBioCryst Pharmaceuticals$8.17+0.6%Moderate Buy$20.50 150.9%122.3451 of 5 starsAnalyst Forecast0.24%LGNDLigand Pharmaceuticals$302.96+0.1%Buy$337.89 11.5%103.4621 of 5 stars0.23%BTSGBrightSpring Health Services$60.25+5.2%Buy$70.71 17.4%204.3522 of 5 starsAnalyst Forecast This page (NYSEARCA:GSSC) was last updated on 10/4/2026 by MarketBeat.com Staff. From Our PartnersElon Warns "America Will Go Bankrupt". Trump's Plan Inside.National debt just crossed 40 trillion dollars, and Elon Musk says America is 1,000% going to go bankrupt with...American Hartford Gold | SponsoredWATCH THIS BEFORE DECEMBER 8th!!James Altucher says a quiet government filing could reveal Elon Musk's biggest move yet, and almost nobody has...Paradigm Press | SponsoredHow Elon’s Empire Ends (and how to profit)Marc Chaikin, the 60 year Wall Street veteran whose Chaikin Money Flow indicator sits on every Bloomberg termi...Chaikin Analytics | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | SponsoredA new kind of civil war is coming after election day?Across America, AI-driven backlash is fueling protests, lawsuits, and moratoria that could reshape the politic...Stansberry Research | SponsoredThese gold assets are priced for $1,800 gold [it's over $4,000]Gold's major miners are generating record free cash flow, with margins as high as 75 percent even after gold's...Golden Portfolio | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredMy top 3 AI picks for the next decadeAlexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
